SCHEMBL455401

SCHEMBL455401

CC=C(C(=O)O)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4969394 1.00
SCHEMBL2803632 0.78 THRB (0.33)
SCHEMBL6916913 0.77
SCHEMBL6916917 0.77
SCHEMBL10041930 0.77
SCHEMBL335029 0.76 GRIK1 (0.35)
SCHEMBL5892077 0.74 KDM4E (0.33)
SCHEMBL8172310 0.74 TSHR (0.30)
SCHEMBL13560395 0.74 TDP1 (0.30)
SCHEMBL13560398 0.74 TDP1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4550061-A Electroerosion printing media using depolymerizable polymer coatings INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 1985-10-29 US claimed
EP-0158276-A2 Electroerosion printing media LEXMARK INTERNATIONAL, INC. (US) 1985-10-16 EP claimed
EP-4214277-A1 SULFIDE-CONTAINING STABILIZER SYSTEM FOR THIOL-ENE AND THIOL-YNE COMPOSITIONS Bruno Bock GmbH (DE) 2023-07-26 EP disclosed
US-10407482-B2 Amino acid substituted molecules ALLOZYNE, INC. (US) 2019-09-10 US disclosed
US-10202447-B2 Antibody derivatives MEDIMMUNE LIMITED (GB) 2019-02-12 US disclosed
EP-2640745-B1 BIVALENT AND BISPECIFIC ANTI-IL6/ANTI-IL23 ANTIBODIES MEDIMMUNE LTD (GB) 2018-11-07 EP disclosed
US-20160194391-A1 ANTIBODY DERIVATIVES ALLOZYNE, INC. 2016-07-07 US disclosed
US-20140255345-A1 AMINO ACID SUBSTITUTED MOLECULES ALLOZYNE, INC. (US) 2014-09-11 US disclosed
US-20140127209-A1 ANTIBODY DERIVATIVES MEDIMMUNE LIMITED (GB) 2014-05-08 US disclosed
US-8568706-B2 Modified human interferon-beta polypeptides ALLOZYNE, INC. (US) 2013-10-29 US disclosed
EP-2640745-A2 ANTIBODY DERIVATIVES Allozyne, Inc. (US) 2013-09-25 EP disclosed
US-20080214439-A1 AMINO ACID SUBSTITUTED MOLECULES ALLOZYNE, INC. (US) 2008-09-04 US disclosed
US-20080200641-A1 AMINO ACID SUBSTITUTED MOLECULES ALLOZYNE, INC. (US) 2008-08-21 US disclosed
EP-1954668-A2 HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS Brystol-Myers Squibb Company (US) 2008-08-13 EP disclosed
US-20080125347-A1 AMINO ACID SUBSTITUTED MOLECULES ALLOZYNE, INC. (US) 2008-05-29 US disclosed
US-20080096819-A1 Amino acid substituted molecules ALLOZYNE, INC. (US) 2008-04-24 US disclosed
US-20080085473-A1 lithographic photoresist; deep UV, x-ray, electon beam: alpha-cyano- or an alpha-trifluoro methacrylate monomer and a vinyl ether monomer; 157 nm. GLOBALFOUNDRIES U.S. INC. 2008-04-10 US disclosed
WO-2007130453-A2 NON-NATURAL AMINO ACID SUBSTITUTED POLYPEPTIDES ALLOZYNE, INC. (US) 2007-11-15 WO disclosed
WO-2007062308-A2 HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-05-31 WO disclosed
US-5354633-A Ignition layer, ignitable metal layer, and mechanically strong, durable, flexible third layer PRESSTEK, INC. (US) 1994-10-11 US disclosed